{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:03:59Z","timestamp":1788037439315,"version":"build-2784847793"},"reference-count":19,"publisher":"Oceanside Publications Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:p>Hereditary angioedema (HAE) is a rare, autosomal dominant disease caused by a deficiency in the C1-inhibitor protein. It is characterized by recurrent episodes of nonpruritic, nonpitting, subcutaneous or submucosal edema that typically involves the extremities or the gastrointestinal\n tract. However, the genitourinary tract, face, oropharynx, and\/or larynx may be affected as well. Symptoms often begin in childhood, worsen at puberty, and persist throughout life, with unpredictable severity. Patients who are untreated may have frequent attacks, with intervals that can range\n from every few days to rare episodes. Minor trauma and stress are frequent precipitants of swelling episodes, but many attacks occur without clear triggers. HAE attacks may be preceded by a prodrome and\/or be accompanied by erythema marginatum. The swelling typically worsens over the first\n 24 hours, before gradually subsiding over the subsequent 48 to 72 hours. Although oropharyngeal swelling is less frequent, more than half of patients have had at least one episode of laryngeal angioedema during their lifetime. Attacks may start in one location and spread to another before\n resolving. HAE attacks that involve the abdomen or oropharynx have been associated with significant morbidity and mortality. Abdominal attacks can cause severe abdominal pain, nausea, and vomiting. Bowel sounds are often diminished or silent, and guarding and rebound tenderness may be present\n on physical examination. These findings may lead to unnecessary abdominal imaging and procedures. Fluid shifts into the interstitial space or peritoneal cavity can cause clinically significant hypotension. Laryngeal edema poses the greatest risk for patients with HAE. Although prompt diagnosis\n and treatment improves outcomes, the variable presentation of HAE can make it difficult to diagnose.<\/jats:p>","DOI":"10.2500\/aap.2020.41.200065","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T04:41:14Z","timestamp":1603860074000},"page":"S18-S21","source":"Crossref","is-referenced-by-count":33,"title":["Clinical presentation of hereditary angioedema"],"prefix":"10.2500","volume":"41","author":[{"given":"Veronica","family":"Azmy","sequence":"first","affiliation":[{"name":"From the Section of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel P.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Division of Allergy and Immunology, Children\u2019s National Hospital, Washington, D.C.; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Ida","family":"Hsu","sequence":"additional","affiliation":[{"name":"From the Section of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/DCC.0000000000000188","article-title":"Angioedema: clinical presentations and pharmacological management","volume":"35","author":"Collins-Yoder","year":"2016","journal-title":"Dimens Crit Care Nurs"},{"key":"B2","first-page":"41","article-title":"Clinical presentation, pathophysiology, diagnosis, and treatment of acquired and hereditary angioedema: exploring state-of-the-art therapies in RI","volume":"99","author":"Guo","year":"2013","journal-title":"R I Med J"},{"key":"B3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaip.2019.10.003","article-title":"C1 Inhibitor activity and angioedema attacks in patients with hereditary angioedema","volume":"8","author":"Kaplan","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B4","first-page":"353","article-title":"Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema","volume":"24","author":"Nzeako","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"925861","DOI":"10.1155\/2015\/925861","article-title":"Hereditary angioedema and gastrointestinal complications: an extensive review of the literature","volume":"2015","author":"Patel","year":"2015","journal-title":"Case Reports Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2500\/aap.2020.41.200081","article-title":"Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH)","volume":"41","author":"Wedner","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.iac.2013.07.002","article-title":"Hereditary angioedema with normal C1 inhibitor","volume":"33","author":"Bork","year":"2013","journal-title":"Immunol Allergy Clin North Am"},{"key":"B8","first-page":"S1","article-title":"Hereditary angioedema: an instructive model of clinical description, molecular discovery, and development of new effective treatments","volume":"32(","author":"Bellanti","year":"2011","journal-title":"Allergy Asthma Proc"},{"key":"B9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","article-title":"Hereditary angioedema: new findings concerning symptoms, affected organs, and course","volume":"119","author":"Bork","year":"2006","journal-title":"Am J Med"},{"key":"B10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-6-24","article-title":"International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema","volume":"6","author":"Bowen","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B11","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s12325-012-0053-5","article-title":"Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks","volume":"29","author":"Prematta","year":"2012","journal-title":"Adv Ther"},{"key":"B12","first-page":"197","article-title":"Chicken-wire erythema, but not urticaria, as the presenting sign of hereditary angioedema","volume":"16","author":"Yucelten","year":"2006","journal-title":"Eur J Dermatol"},{"key":"B13","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.2500\/aap.2020.41.200062","article-title":"Hereditary angioedema: differential diagnosis, diagnostic tests and family screening","volume":"41","author":"Manning","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaci.2018.01.015","article-title":"Hereditary angioedema with normal C1 inhibitor: four types and counting","volume":"141","author":"Zuraw","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.amjmed.2007.08.021","article-title":"Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course","volume":"120","author":"Bork","year":"2007","journal-title":"Am J Med"},{"key":"B17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","article-title":"Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy","volume":"124","author":"Bork","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01526-7","article-title":"Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy","volume":"114","author":"Bork","year":"2003","journal-title":"Am J Med"},{"key":"B19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9343(91)80179-P","article-title":"Contraindications to the use of ace inhibitors in patients with C1 esterase inhibitor deficiency","volume":"90","author":"Agostoni","year":"1991","journal-title":"Am J Med"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2020\/00000041\/a00106s1\/art00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T04:43:38Z","timestamp":1603860218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2020.41.200065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11,1]]}},"alternative-id":["1088-5412(20201101)41:6+L.18;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2020.41.200065","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,1]]}}}